CN104922240A - 一种专治口腔癌的中药 - Google Patents
一种专治口腔癌的中药 Download PDFInfo
- Publication number
- CN104922240A CN104922240A CN201410109191.5A CN201410109191A CN104922240A CN 104922240 A CN104922240 A CN 104922240A CN 201410109191 A CN201410109191 A CN 201410109191A CN 104922240 A CN104922240 A CN 104922240A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- oral cancer
- traditional chinese
- specially used
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及医药的技术领域，具体地说是一种专治口腔癌的中药。该中药按以下重量份组成：小茴香杆1-10份,枣仁2-10份,冰糖5-12份,杏仁0.7-3份,西茴8-17份。本发明的目的是提供一种安全方便、没有副作用的专治口腔癌的中药。
Description
技术领域
本发明涉及医药的技术领域，具体地说是一种专治口腔癌的中药。
背景技术
口腔癌是发生在口腔的恶性肿瘤之总称，大部分属于鳞状上皮细胞癌，即所谓的黏膜发生变异，是头颈部较常见的恶性肿瘤之一。目前，治疗口腔癌的方法有手术切除、放射线治疗、化学治疗、中药治疗等。而不同的方式是适用于不同时期的口腔癌的。早期的口腔癌适宜单独使用手术或放射治疗，而中晚期的口腔癌则适合使用外科手术合并术后与放射线治疗。但总的来说，这些疗法都不明显。
发明内容
本发明的目的是提供一种安全方便、没有副作用的专治口腔癌的中药。
本发明采用的技术方案是，一种专治口腔癌的中药，所述材料按以下重量份组成：小茴香杆1-10份,枣仁2-10份,冰糖5-12份,杏仁0.7-3份,西茴8-17份。
本发明的优点是安全方便、没有副作用。
具体实施方式
本发明结合以下实施例作进一步描述。
实施例1，一种专治口腔癌的中药，所述材料按以下重量份组成：小茴香杆1份,枣仁2份,冰糖5份,杏仁0.7份,西茴8份。
实施例2，一种专治口腔癌的中药，所述材料按以下重量份组成：小茴香杆5份,枣仁7份,冰糖9份,杏仁2份,西茴12份。
实施例3，一种专治口腔癌的中药，所述材料按以下重量份组成：小茴香杆10份,枣仁10份,冰糖12份,杏仁3份,西茴17份。
应理解，该实施例仅用于说明本发明而不用于限制本发明的范围。此外，应理解，在阅读了本发明讲授的内容之后，本领域技术人员可以对本发明作各种改动或修改，这些等价形式同样落于本申请所附权利要求书所限定的保护范围之内。
Claims (1)
1.一种专治口腔癌的中药，其特征在于，所述材料按以下重量份组成：小茴香杆1-10份,枣仁2-10份,冰糖5-12份,杏仁0.7-3份,西茴8-17份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410109191.5A CN104922240A (zh) | 2014-03-21 | 2014-03-21 | 一种专治口腔癌的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410109191.5A CN104922240A (zh) | 2014-03-21 | 2014-03-21 | 一种专治口腔癌的中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104922240A true CN104922240A (zh) | 2015-09-23 |
Family
ID=54109893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410109191.5A Pending CN104922240A (zh) | 2014-03-21 | 2014-03-21 | 一种专治口腔癌的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104922240A (zh) |
-
2014
- 2014-03-21 CN CN201410109191.5A patent/CN104922240A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY197324A (en) | Adenovirus armed with bispecific t cell activator | |
| MX2017007321A (es) | Terapias de combinacion. | |
| MX2021004821A (es) | Uso de antagonistas contra muerte programada 1 (pd-1) y ligando de muerte programada 1 (pd-l1) en combinacion con radioterapia. | |
| MX2018001263A (es) | Nueva combinacion para el uso en el tratamiento del cancer. | |
| NZ746338A (en) | Use of alphavirus and zap inhibitor in the preparation of an antitumor drug, and antitumor drugs comprising the same | |
| JO3606B1 (ar) | معدل مستقبل الأندروجين في توليفة مع أسيتات أبراتيرون وبريدنيزون لعلاج سرطان البروستاتا | |
| EP3699270A4 (en) | RECOMBINATED ONCOLYTIC ADENOVIRUS ISOLATED, PHARMACEUTICAL COMPOSITION, AND APPLICATION OF RECOMBINATED ONCOLYTIC ADENOVIRUS ISOLATED IN A MEDICINAL PRODUCT FOR THE TREATMENT OF TUMOR AND / OR CANCER | |
| WO2019126739A8 (en) | Pyrvinium pamoate anti-cancer therapies | |
| MX2015012922A (es) | Tratamiento del cancer usando anticuerpos que se unen a grp78 en la superficie celular. | |
| WO2016160621A3 (en) | Nk-92 cells in combination therapy with cancer drugs | |
| EP3639829A4 (en) | USE OF ISOVALERYLSPIRAMYCIN I, II AND / OR III IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT AND / OR PREVENTION OF A TUMOR, AND A MEDICINAL PRODUCT | |
| MX2018011984A (es) | Extractos de uva y métodos relacionados con los mismos. | |
| BR112017019189A8 (pt) | Agente terapêutico celular para tratamento de câncer e terapia de combinação com o mesmo | |
| EP3331356A4 (en) | PROGRANULIN (PGRN) FRAGMENTS AND DERIVATIVES FOR THE TREATMENT OR AID OF LYSOSOMAL STORAGE DISEASES | |
| PH12016501554A1 (en) | Anticancer adjuvant composition containing rip3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting rip3 expression, and method for monitoring sensitivity of anticancer drug | |
| PH12016501407A1 (en) | Treatment of neoplasia | |
| EP3597207A4 (en) | COMPOSITION TYPE OF TRADITIONAL CHINESE MEDICINE FOR TREATMENT OF TUMORS, METHOD OF MANUFACTURING THEREOF AND USES THEREOF | |
| BR112017012022A2 (pt) | complexos macromoleculares de metais de transição para o tratamento do cancro e seu processo de preparação | |
| AU2018244925A1 (en) | Compositions for the treatment of drug-resistant tumors and methods of use thereof | |
| CN104922240A (zh) | 一种专治口腔癌的中药 | |
| MY194694A (en) | Method and composition for treating cancer or skin lesion using a vaccine | |
| PH12017500754A1 (en) | Cancer and skin lesion treatment | |
| MX2021001081A (es) | Terapia de combinacion para el tratamiento del cancer. | |
| MY197942A (en) | Adjuvant therapy for use in prostate cancer treatment | |
| CN104922274A (zh) | 一种专治抑郁症的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150923 |